Differential CD133 expression distinguishes malignant from benign papillary lesions of the breast

Virchows Archiv

Volumn 466, Issue 2, 2015, Pages 177-184

  Lin, Chih Hung ^a   Liu, Chia Hsing ^a   Wen, Chien Hui ^a   Ko, Pei Ling ^a   Chai, Chee Yin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast tumors; CD133; Immunohistochemical; Papillary carcinoma; Stem cells

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOMA; BREAST PAPILLOMA; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH VESSEL METASTASIS; MALIGNANT NEOPLASTIC DISEASE; PAPILLARY CARCINOMA; PERINEURAL INVASION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; BIOSYNTHESIS; BREAST TUMOR; FEMALE; MALE; PATHOLOGY;

ANTIGENS, CD; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PAPILLOMA, INTRADUCTAL; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 84925520200     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1695-2     Document Type: Article

References (24)

1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO classification of tumours of the breast, 4th, edth edn. IARC, Lyon
2. Louwman MW, Vriezen M, van Beek MW, Nolthenius-Puylaert MC, van der Sangen MJ, Roumen RM, Kiemeney LA, Coebergh JW (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121:127–135
3. McCulloch GL, Evans AJ, Yeoman L, Wilson AR, Pinder SE, Ellis IO, Elston CW (1997) Radiological features of papillary carcinoma of the breast. Clin Radiol 52:865–868
4. Grabowski J, Salzstein SL, Sadler GR, Blair S (2008) Intracystic papillary carcinoma: a review of 917 cases. Cancer 113:916–920
5. Battula VL, Shi Y, Evans KW, Wang RY, Spaeth EL, Jacamo RO, Guerra R, Sahin AA, Marini FC, Hortobagyi G, Mani SA, Andreeff M (2012) Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest 122:2066–2078
6. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339–9344
7. Takahashi RU, Takeshita F, Fujiwara T, Ono M, Ochiya T (2011) Cancer stem cells in breast cancer. Cancers (Basel) 3:1311–1328
8. Iqbal J, Chong PY, Tan PH (2013) Breast cancer stem cells: an update. J Clin Pathol 66:485–490
9. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760
10. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323
11. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755–768
12. Zhao P, Lu Y, Jiang X, Li X (2011) Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma. Cancer Sci 102:1107–1111
13. Nadal R, Ortega FG, Salido M, Lorente JA, Rodriguez-Rivera M, Delgado-Rodriguez M, Macia M, Fernandez A, Corominas JM, Garcia-Puche JL, Sanchez-Rovira P, Sole F, Serrano MJ (2013) CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int J Cancer 133:2398–2407
14. Pathmanathan N, Albertini AF, Provan PJ, Milliken JS, Salisbury EL, Bilous AM, Byth K, Balleine RL (2010) Diagnostic evaluation of papillary lesions of the breast on core biopsy. Mod Pathol 23:1021–1028
15. Collins LC, Schnitt SJ (2008) Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 52:20–29
16. Pal SK, Lau SK, Kruper L, Nwoye U, Garberoglio C, Gupta RK, Paz B, Vora L, Guzman E, Artinyan A, Somlo G (2010) Papillary carcinoma of the breast: an overview. Breast Cancer Res Treat 122:637–645
17. Tokiniwa H, Horiguchi J, Takata D, Kikuchi M, Rokutanda N, Nagaoka R, Sato A, Odawara H, Tozuka K, Oyama T, Takeyoshi I (2011) Papillary lesions of the breast diagnosed using core needle biopsies. Exp Ther Med 2:1069–1072
18. Tse GM, Tan PH, Moriya T (2009) The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast. J Clin Pathol 62:407–413
19. Di Cristofano C, Mrad K, Zavaglia K, Bertacca G, Aretini P, Cipollini G, Bevilacqua G, Ben Romdhane K, Cavazzana A (2005) Papillary lesions of the breast: a molecular progression? Breast Cancer Res Treat 90:71–76
20. Lininger RA, Park WS, Man YG, Pham T, MacGrogan G, Zhuang Z, Tavassoli FA (1998) LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol 29:1113–1118
21. Troxell ML, Levine J, Beadling C, Warrick A, Dunlap J, Presnell A, Patterson J, Shukla A, Olson NR, Heinrich MC, Corless CL (2010) High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol 23:27–37
22. Aomatsu N, Yashiro M, Kashiwagi S, Takashima T, Ishikawa T, Ohsawa M, Wakasa K, Hirakawa K (2012) CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer. PLoS One 7:e45865
23. Ohtsubo I, Ajiki T, Hori Y, Murakami S, Shimizu K, Itoh T, Shimizu M, Fukumoto T, Ku Y (2012) Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas. Hepatol Res 42:574–582
24. Shimizu K, Itoh T, Shimizu M, Ku Y, Hori Y (2009) CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas. Pancreas 38:e207–e214